A detailed history of Oxford Wealth Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Oxford Wealth Group, LLC holds 7,223 shares of NVS stock, worth $701,208. This represents 0.68% of its overall portfolio holdings.

Number of Shares
7,223
Previous 10,196 29.16%
Holding current value
$701,208
Previous $1.09 Billion 23.46%
% of portfolio
0.68%
Previous 0.75%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $315,524 - $359,405
-2,973 Reduced 29.16%
7,223 $831 Million
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $314,367 - $364,628
3,396 Added 49.94%
10,196 $1.09 Billion
Q1 2024

May 16, 2024

BUY
$95.27 - $108.47 $647,836 - $737,596
6,800 New
6,800 $658 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Oxford Wealth Group, LLC Portfolio

Follow Oxford Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxford Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxford Wealth Group, LLC with notifications on news.